Waldenström Macroglobulinemia
Waldenström Macroglobulinemia (WM), also called Waldenstrom’s, is a type of Non-Hodgkin Lymphoma (NHL). It is a rare type of cancer that begins in the white blood cells when your bone marrow produces too many abnormal white blood cells that crowd out healthy blood cells.
This site provides general information. Please talk to your own doctor to make healthcare decisions that are right for you.
What’s New?
https://powerfulpatients.org/wp-content/uploads/Returning-To-Work-After-Cancer-Treatment-1.png
600
600
Marie Ennis-O'Connor
https://powerfulpatients.org/wp-content/uploads/New-Logo-300x126.png
Marie Ennis-O'Connor2018-12-20 16:29:422022-09-09 11:51:25Returning To Work During or After Cancer Treatment: Part 2
https://powerfulpatients.org/wp-content/uploads/What-Is-the-Value-of-Diversity-in-Clinical-Trials_-1.png
600
600
PEN Editorial Staff
https://powerfulpatients.org/wp-content/uploads/New-Logo-300x126.png
PEN Editorial Staff2018-12-05 19:48:512024-03-04 13:04:36What Is the Value of Diversity in Clinical Trials?
https://powerfulpatients.org/wp-content/uploads/Returning-To-Work-After-Cancer-Treatment.png
600
600
Marie Ennis-O'Connor
https://powerfulpatients.org/wp-content/uploads/New-Logo-300x126.png
Marie Ennis-O'Connor2018-11-26 17:14:522022-02-22 16:14:08Returning To Work After Cancer Treatment. Part 1: Preparing the Ground
https://powerfulpatients.org/wp-content/uploads/Clinical-Trial-MythBusters.png
600
600
Kara Rayburn
https://powerfulpatients.org/wp-content/uploads/New-Logo-300x126.png
Kara Rayburn2018-09-18 17:13:312024-03-04 13:04:36Clinical Trial MythBusters: Actionable Advice for Knocking Down Obstacles to Trial Participation
